Revascularization Strategies for Multivessel Coronary Artery Disease in the Elderly Population
Nicholas R Hess1, Arman Kilic2, Yisi Wang3
1Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine.
Insights
Coronary artery bypass grafting (CABG) offers improved 5-year survival for elderly patients with multivessel coronary disease compared to percutaneous coronary intervention (PCI). Multidisciplinary evaluation is recommended for older patients with multivessel coronary disease.
Area of Science:
- Cardiology
- Geriatric Medicine
- Interventional Cardiology
Background:
- Previous trials on coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) for multivessel coronary disease (MVCAD) primarily included younger patients.
- The elderly population's treatment strategies for MVCAD remain understudied.
Purpose of the Study:
- To compare the effectiveness of CABG and PCI in elderly patients (≥75 years) with MVCAD.
- To evaluate long-term survival and adverse events in this demographic.
Main Methods:
- A propensity-score-matched analysis of patients ≥75 years undergoing isolated CABG or PCI for MVCAD between 2011 and 2018.
- Exclusion criteria included prior cardiac surgery and significant left main disease.
- Primary outcome: 5-year Kaplan-Meier survival; Secondary outcomes: readmissions and major adverse cardiovascular and cerebrovascular events (MACCE).
Main Results:
- Propensity matching included 536 patients (266 PCI, 266 CABG).
- CABG achieved higher complete revascularization rates (86.8% vs. 21.8%).
- Five-year survival was significantly higher with CABG (73.8% vs. 60.1%, P=0.0332), despite similar 30-day mortality and shorter hospital stays with PCI.
Conclusions:
- CABG is associated with improved late survival in elderly patients with MVCAD compared to PCI, despite longer hospitalization.
- Cardiac surgeons should be involved in the multidisciplinary evaluation of older patients with MVCAD.
- No significant 5-year survival benefit was observed from multi-arterial grafting in CABG patients.
Background:
Prospective trials comparing coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) for the treatment of multivessel coronary disease (MVCAD) have included mostly younger patients. We compared treatment strategies in the elderly population.
Materials And Methods:
We performed a propensity-score-matched comparison of patients ≥75 y who underwent isolated CABG or PCI for MVCAD between 2011 and 2018, excluding those with prior cardiac surgery and/or significant left main disease. The primary outcome was 5-year Kaplan Meier survival, and secondary outcomes included readmissions and major adverse cardiovascular and cerebrovascular events (MACCE).
Results:
Propensity-matching yielded 536 patients (266 PCI and 266 CABG). Rates of complete revascularization of all stenotic lesions were higher in the CABG arm (86.8% versus 21.8%; P < 0.001). Thirty-d mortality was similar between cohorts, though PCI recipients had shorter hospital stay and greater likelihood of discharge to home. Unadjusted one- (89.1% versus 88.4%) and 5-year (73.8% versus 60.1%) survival were both higher in patients who underwent CABG (P = 0.0332). Patients undergoing CABG had reduced, but nonsignificant cumulative incidence of all-cause hospital readmission and MACCE at 5 y. Subgroup analysis of patients 80 y or older revealed similar late survival benefit with CABG when compared to PCI. Among patients undergoing CABG, there did not appear to be any 5-year benefits from multi-arterial grafting.
Conclusions:
Despite longer hospitalization and higher rate of nonhome discharge, CABG was associated with improved late survival over PCI in the elderly population. Cardiac surgeons should be included in the multidisciplinary evaluation of older patients with MVCAD.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures


